NO20065722L - Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. - Google Patents
Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.Info
- Publication number
- NO20065722L NO20065722L NO20065722A NO20065722A NO20065722L NO 20065722 L NO20065722 L NO 20065722L NO 20065722 A NO20065722 A NO 20065722A NO 20065722 A NO20065722 A NO 20065722A NO 20065722 L NO20065722 L NO 20065722L
- Authority
- NO
- Norway
- Prior art keywords
- aerosol formulation
- chemical stability
- improved chemical
- linking agent
- butyl rubber
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title abstract 2
- 229920005549 butyl rubber Polymers 0.000 abstract 2
- 239000003431 cross linking reagent Substances 0.000 abstract 2
- 229940071648 metered dose inhaler Drugs 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- SKOLWUPSYHWYAM-UHFFFAOYSA-N carbonodithioic O,S-acid Chemical class SC(S)=O SKOLWUPSYHWYAM-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 229940127212 long-acting beta 2 agonist Drugs 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229920001021 polysulfide Polymers 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 238000007789 sealing Methods 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04011425 | 2004-05-13 | ||
| PCT/EP2005/002041 WO2005112902A2 (en) | 2004-05-13 | 2005-02-25 | Medicinal aerosol formulation products with improved chemical stability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065722L true NO20065722L (no) | 2006-12-12 |
Family
ID=34960892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065722A NO20065722L (no) | 2004-05-13 | 2006-12-12 | Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070086953A1 (pt) |
| EP (1) | EP1746981B1 (pt) |
| JP (1) | JP2007537170A (pt) |
| KR (1) | KR20070010159A (pt) |
| CN (1) | CN1950075A (pt) |
| AT (1) | ATE404185T1 (pt) |
| AU (1) | AU2005245248A1 (pt) |
| BR (1) | BRPI0510852A (pt) |
| CA (1) | CA2565747A1 (pt) |
| DE (1) | DE602005008946D1 (pt) |
| EA (1) | EA200602112A1 (pt) |
| ES (1) | ES2309722T3 (pt) |
| IL (1) | IL178739A0 (pt) |
| MA (1) | MA28649B1 (pt) |
| MX (1) | MXPA06013189A (pt) |
| NO (1) | NO20065722L (pt) |
| TN (1) | TNSN06334A1 (pt) |
| WO (1) | WO2005112902A2 (pt) |
| ZA (1) | ZA200608742B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20186870B (en) * | 2013-12-30 | 2018-06-25 | Chiesi Farma Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| HUE039513T2 (hu) * | 2013-12-30 | 2019-01-28 | Chiesi Farm Spa | Glikopirrónium-bromid és formoterol kombinációját tartalmazó nyomás alatti stabil aeroszol oldatkészítmény |
| CN106620976B (zh) * | 2016-12-28 | 2020-01-07 | 四川普锐特医药科技有限责任公司 | 一种丙酸氟替卡松定量吸入气雾剂 |
| GB202001537D0 (en) | 2020-02-05 | 2020-03-18 | Consort Medical Plc | Pressurised dispensing container |
| MX2023003754A (es) * | 2020-10-09 | 2023-04-24 | Chiesi Farm Spa | Formulacion farmaceutica para inhalador presurizado de dosis medidas. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| EE05167B1 (et) * | 2000-05-22 | 2009-06-15 | Chiesi Farmaceutici S.P.A. | Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele |
| DK3384931T3 (da) * | 2002-03-01 | 2019-09-16 | Chiesi Farm Spa | Superfin formoterolformulering |
| US20040126325A1 (en) * | 2002-03-12 | 2004-07-01 | David Lewis | Medicinal aerosol solution formulation products with improved chemical stability |
| US7736712B2 (en) * | 2002-03-18 | 2010-06-15 | Consort Medical Plc | Seal material for a dispensing apparatus |
| EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| IL177103A0 (en) * | 2004-02-27 | 2006-12-10 | Chiesi Farma Spa | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| KR101313959B1 (ko) * | 2005-02-25 | 2013-10-02 | 키에시 파르마슈티시 엣스. 피. 에이. | 금속이온 봉쇄제로 구성되는 압축계량된 도스 흡입기용약제 에어로졸 조성물 |
-
2005
- 2005-02-25 AT AT05715569T patent/ATE404185T1/de not_active IP Right Cessation
- 2005-02-25 CA CA002565747A patent/CA2565747A1/en not_active Abandoned
- 2005-02-25 EA EA200602112A patent/EA200602112A1/ru unknown
- 2005-02-25 WO PCT/EP2005/002041 patent/WO2005112902A2/en not_active Ceased
- 2005-02-25 DE DE602005008946T patent/DE602005008946D1/de not_active Expired - Lifetime
- 2005-02-25 CN CNA2005800147005A patent/CN1950075A/zh active Pending
- 2005-02-25 AU AU2005245248A patent/AU2005245248A1/en not_active Abandoned
- 2005-02-25 EP EP05715569A patent/EP1746981B1/en not_active Expired - Lifetime
- 2005-02-25 BR BRPI0510852-7A patent/BRPI0510852A/pt not_active IP Right Cessation
- 2005-02-25 ES ES05715569T patent/ES2309722T3/es not_active Expired - Lifetime
- 2005-02-25 MX MXPA06013189A patent/MXPA06013189A/es not_active Application Discontinuation
- 2005-02-25 KR KR1020067022859A patent/KR20070010159A/ko not_active Withdrawn
- 2005-02-25 JP JP2007511888A patent/JP2007537170A/ja active Pending
-
2006
- 2006-10-13 TN TNP2006000334A patent/TNSN06334A1/en unknown
- 2006-10-19 IL IL178739A patent/IL178739A0/en unknown
- 2006-10-19 ZA ZA200608742A patent/ZA200608742B/en unknown
- 2006-11-10 US US11/558,793 patent/US20070086953A1/en not_active Abandoned
- 2006-12-04 MA MA29511A patent/MA28649B1/fr unknown
- 2006-12-12 NO NO20065722A patent/NO20065722L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1746981B1 (en) | 2008-08-13 |
| WO2005112902A2 (en) | 2005-12-01 |
| KR20070010159A (ko) | 2007-01-22 |
| TNSN06334A1 (en) | 2008-02-22 |
| US20070086953A1 (en) | 2007-04-19 |
| BRPI0510852A (pt) | 2007-11-27 |
| ES2309722T3 (es) | 2008-12-16 |
| AU2005245248A1 (en) | 2005-12-01 |
| EA200602112A1 (ru) | 2007-04-27 |
| CA2565747A1 (en) | 2005-12-01 |
| IL178739A0 (en) | 2007-02-11 |
| DE602005008946D1 (de) | 2008-09-25 |
| JP2007537170A (ja) | 2007-12-20 |
| MA28649B1 (fr) | 2007-06-01 |
| EP1746981A2 (en) | 2007-01-31 |
| ATE404185T1 (de) | 2008-08-15 |
| MXPA06013189A (es) | 2007-02-14 |
| WO2005112902A3 (en) | 2006-05-04 |
| ZA200608742B (en) | 2008-07-30 |
| CN1950075A (zh) | 2007-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR130239A2 (es) | Método para reducir la cantidad del producto de degradación dp3 durante la vida de estante de una composición farmacéutica en solución para aerosol y uso de una lata de aerosol asociada | |
| ES2618829T3 (es) | Sello para un aparato dispensador | |
| DK0616525T3 (da) | Medikamenter | |
| AU2024219491B2 (en) | Pressurised dispensing container | |
| MY143075A (en) | Stable pharmaceutical solution formulations for pressurized metered dose inhalers. | |
| BR0208363A (pt) | Produtos de formulação de solução aerossol medicinal com estabilidade quìmica melhorada | |
| DE60310899T2 (de) | Dichtungsmaterial für eine spenderapparatur | |
| NO20065722L (no) | Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. | |
| WO2005016410A3 (en) | Pharmaceutical metered dose inhaler and methods relating thereto | |
| WO2007020204A3 (en) | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate | |
| BR112012008983A2 (pt) | "formulação medicinal em suspensão, composição farmacêutica, produto, uso de cromolina sódica,e, método para aumentar a estabilidade de uma formulação medicinal em suspensão de aerossol." | |
| GB2410500A (en) | Seal for a pharmaceutical dispensing device | |
| WO2017021698A1 (en) | Seal for a dispensing apparatus | |
| BRPI0609029B1 (pt) | Dispositivo de dispensação farmacêutica | |
| BRPI0408003A (pt) | produtos antiperspirante/desodorizante em aerossol | |
| WO2004103339A3 (en) | Improved metered dose inhaler | |
| GB2415699A (en) | Seal material for a dispensing apparatus | |
| BR0012907A (pt) | Agente para o remédio de dano neural, composto contendo nitrogênio, e, composição farmacêutica | |
| GB2445483A (en) | Seal for a pharmaceutical dispensing device | |
| BRPI0405842B8 (pt) | composição farmacêutica estabilizada de composto flúor-éter para uso anestésico. método para estabilizar um composto flúor-éter. uso de agente estabilizante para impedir a degradação de composto flúor éter. | |
| BR112019005168A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica | |
| AR048418A1 (es) | Formulaciones de soluciones medicinales estables para inhaladores de cartucho presurizados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |